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Background
Patients with end stage dilated cardiomyopathy exhibit
extensive remodeling of the left ventricle, annular dilation,
and significant mitral and tricuspid regurgitation. These
changes increase perioperative morbidity and mortality,
and emphasize patient candidacy for heart transplantation.
We previously published that Reductive Annuloplasty of
Double (mitral and tricuspid) Orifices could be success-
fully applied in selective patients. However, it was unclear
if implantation of the artificial mitral valve with preserva-
tion of native mitral valve could be used as a method in
such cases.
Methods
There were 16 patients (13 males, 3 females) with
ischemic dilated cardiomyopathy, mean ejection fraction
below 30% (26.6±3.1%), and mean left ventricle end-dia-
stolic internal diameter greater than 7.0cm (7.3±0.3 cm)
with coaptation depth of the mitral valve (tenting area)
significantly lower than 1.1cm. In addition to myocardial
revascularization mechanical or biological artificial valve
were implanted in 12 and 4 patients respectively. Modified
De Vega tricuspid annuloplasty was performed in all
patients.
Results
There was no postoperative 30-day mortality. Survival
rate after 5 years was 93.75%.
Conclusion
Reverse remodeling of the left ventricle by CABG surgery
followed with implantation of the artificial mitral valve
and tricuspid suture annuloplasty could be successfully
applied in selective patients with ischemic dilative
cardiomyopathy. Our method should not be recognized as
a valve repair, but ventricular repair procedure also.
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